23 May 2013
Keywords: mylan, loyal, king, buy, despite, icahn, filing
Article | 20 September 2004
Mylan Laboratories, the largest generic drugmaker in the USA, was forcedto defend its offer for King Pharmaceuticals following investor Carl ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.